New Web Site Helps Patients Find Stanford Clinical Trials More Easily
Posted on: Monday, 12 November 2007, 15:00 CST
Until now, if you wanted to find out about the types of clinical trials being conducted at Stanford University, your only option was to type a few phrases into Google and hope for the best.
But that changed Nov. 9 with the launch of a single, comprehensive, publicly accessible database of the clinical trials at Stanford and its affiliated facilities. The database is available at http://clinicaltrials.stanford.edu.
In addition to its value as a resource for researchers, the new registry will be a huge boon to patients hoping to find clinical trials that match their medical needs.
"The Web is increasingly used by patients and referring physicians as the primary mechanism to learn about clinical trials," said Harry Greenberg, MD, senior associate dean for research at Stanford's School of Medicine. "To date, finding comprehensive information about studies at Stanford has been extremely difficult. By providing a single, easy-to-use Web site, this system helps the public to more easily discover Stanford's studies."
At any one time, about 1,000 clinical trials are going on at Stanford, with about 300 trials beginning and 300 trials ending each year, said Steven Alexander, MD, medical director of the Stanford/Packard Center for Translational Research in Medicine, the organization that oversees Stanford's clinical trials. Current Stanford studies range from testing a new drug for leukemia, to assessing the impact of meditation on depression, to exploring a novel treatment plan for Hodgkin's disease.
Clinical trials are the proving grounds in which researchers assess the safety and effectiveness of drugs, surgical procedures, medical devices, behavioral treatments and dietary interventions. Most of the early testing is done in laboratory settings and in animal models before moving to the clinical-trial stage, in which human subjects are used. If the clinical trials indicate the treatment is safe and effective, the U.S. Food and Drug Administration usually approves it for use by the broader public.
The oversight of clinical trials has come under increasing scrutiny in recent years; concerns were raised that in some instances, information about privately funded studies was either altered or suppressed when the resulting data were negative. To build more transparency into the process, the International Committee of Medical Journal Editors implemented a policy in July 2005 requiring that clinical trials be registered in a free, publicly available database prior to enrolling patients. Scientists who don't register their studies cannot publish their results in ICMJE publications. By April 2007, more than 40,000 trials had been registered with the database maintained by the National Institutes of Health at http://clinicaltrials.gov.
Clinical trials entered into the new Stanford system will be automatically uploaded to the NIH database, Alexander said, so that investigators don't have to enter the information twice. In addition, information from Stanford's database can be easily shared with collaborating institutions--such as Kaiser and the Palo Alto Medical Foundation--and can also be published on departmental Web sites within the medical school.
The registry will contain all "interventional" clinical studies conducted at Stanford. Interventional studies are those in which the outcome of some type of treatment (drugs, surgical procedures, behavioral treatments) is assessed. Studies that are purely "observational" in nature--for instance, tracking the health and dietary habits of adolescents--do not have to be registered.
Patients looking for information about clinical trials will have four different ways of searching the Stanford database: by condition or disease, by investigator, by department or through a free-text search.
"This will allow patients to go to their primary-care physician and ask if a certain clinical trial might be helpful for them," said Alexander, who is also a professor of pediatrics.
Henry Lowe, MD, senior associate dean for information resources and technology at the medical school, said the database system was designed to allow the clinical trials information to be linked to multiple internal databases in the future. "We are exploring the potential for linking clinical trials descriptions to faculty information in the school's Community Academic Profiles system, to our STRIDE clinical and translational research informatics platform and to the medical center's electronic health record systems," Lowe said.
Stanford University Medical Center integrates research, medical education and patient care at its three institutions -- Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital at Stanford. For more information, please visit the Web site of the medical center's Office of Communication & Public Affairs at http://mednews.stanford.edu.
Source: Business Wire
Related Articles
- QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System
- AVEO Pharmaceuticals Completes Enrollment in Phase 2 Clinical Trial of AV-951 in Patients With Metastatic Renal Cell Carcinoma
- Cytokinetics Announces Positive Results From an Interim Analysis of an Ongoing Phase IIa Clinical Trial of CK-1827452 in Patients With Stable Heart Failure
- Market Research Suggests Internet Recruitment Is Reducing Clinical Trial Costs; 85 Percent of Patients Research Ailments Online
- Abbott Enrolls First Patient in World's First Clinical Trial Designed to Study Drug Eluting Stent Treatment in Women
- First Patient Enrolled in Medtronic's Clinical Trial of the DIAM Spinal Stabilization System
- CancerVax Announces Results of Phase 3 Clinical Trials of Canvaxin(TM) in Patients With Stage III and Stage IV Melanoma
- Human Genome Sciences Reports Results of Phase 2 Clinical Trial of HGS-ETR1 In Patients With Advanced Colorectal Cancer
- ThermoGenesis Corp. Meets Clinical Endpoints of Phase III Clinical Trial of CryoSeal(R) Fibrin Sealant (FS) System
User Comments (0)

RSS Feeds